Full-Life Technologies
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
$150MSeries D+Debt
Role not disclosedCC
Chengwei Capital
Activity from announced rounds
Activity in this selectionjefferies-family-office-9ab84067
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $150M 1 disclosed · full round size, not this investor’s share